Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma. | Cancers (Basel) | 2023 | 37568703 | PubTator, text mining | PubMed |
| RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect. | Cells | 2023 | 37566072 | PubTator, text mining | PubMed |
| BET in hematologic tumors: Immunity, pathogenesis, clinical trials and drug combinations. | Genes Dis | 2023 | 37554207 | PubTator, text mining | PubMed |
| Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. | Front Immunol | 2023 | 37545504 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma. | iScience | 2023 | 37539026 | PubTator, text mining | PubMed |
| Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL). | Clin Epigenetics | 2023 | 37533111 | PubTator, text mining | PubMed |
| SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression. | Cancer Cell Int | 2023 | 37525212 | PubTator, text mining | PubMed |
| Emerging roles of Aurora-A kinase in cancer therapy resistance. | Acta Pharm Sin B | 2023 | 37521867 | PubTator, text mining | PubMed |
| Proximity-Based Modalities for Biology and Medicine. | ACS Cent Sci | 2023 | 37521793 | PubTator, text mining | PubMed |
| Chemogenetic Minitool for Dissecting the Roles of Protein Phase Separation. | ACS Cent Sci | 2023 | 37521779 | PubTator, text mining | PubMed |
| A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors. | Int J Mol Sci | 2023 | 37511270 | PubTator, text mining | PubMed |
| Genetic Abnormalities in Extramedullary Multiple Myeloma. | Int J Mol Sci | 2023 | 37511018 | PubTator, text mining | PubMed |
| Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review. | Diagnostics (Basel) | 2023 | 37510072 | PubTator, text mining | PubMed |
| Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting. | Biomedicines | 2023 | 37509726 | PubTator, text mining | PubMed |
| A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis. | Cells | 2023 | 37508548 | PubTator, text mining | PubMed |
| Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies. | Cells | 2023 | 37508523 | PubTator, text mining | PubMed |
| T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA. | Curr Opin Oncol | 2023 | 37501530 | PubTator, text mining | PubMed |
| Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer. | Int J Biol Sci | 2023 | 37496997 | PubTator, text mining | PubMed |
| DNA framework-engineered chimeras platform enables selectively targeted protein degradation. | Nat Commun | 2023 | 37495569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=32